What to Expect When Starting Peptide Therapy
One of the most common frustrations people have when researching peptide therapy is that the information available online is either vague ("results may vary") or suspiciously optimistic ("feel 20 years younger in 4 weeks"). Neither is particularly useful if you're trying to make an informed decision about whether this is something worth pursuing.
This guide gives you the honest version: what the process actually looks like from start to finish, what labs a clinician will typically want before you begin, how peptides are administered, what a realistic timeline of effects looks like, what side effects are common versus what should prompt you to stop, and who this genuinely isn't appropriate for.
Key Takeaways
- A legitimate peptide therapy program always begins with a physician consultation and baseline lab work — not a peptide shipment.
- Most therapeutic peptides are administered by subcutaneous injection, which patients learn to self-administer at home.
- Results are gradual — the realistic timeline for meaningful, measurable changes is 4–12 weeks depending on the peptide and goal.
- Early effects (weeks 1–4) are often subtle: improved sleep quality and energy are frequently the first things patients notice.
- Peptide therapy requires ongoing monitoring and follow-up — it is not a one-time treatment.
- Certain medical conditions are contraindications — active cancer and pregnancy being the most significant.
The Process: Six Phases of a Legitimate Peptide Protocol
A properly structured peptide therapy program follows a predictable sequence. If a provider is skipping steps — particularly the consultation and labs — that is a meaningful red flag.
Initial Consultation
The process begins with a thorough one-on-one consultation with a licensed clinician — typically a physician, nurse practitioner, or physician assistant with experience in functional or metabolic medicine. This is not a brief intake form: it is a detailed conversation covering your full medical history, current medications and supplements, previous treatments, lifestyle factors, and your specific health goals.
A consultation of this nature typically takes 45 minutes to an hour for a new patient. The clinician will be evaluating not just whether peptide therapy is appropriate, but which specific peptide or combination of peptides — and at what dose and frequency — makes the most sense for your individual profile.[1]
They should also be assessing for contraindications: conditions or circumstances that would make specific peptides inadvisable. This conversation should be genuinely two-way — if a provider is prescribing without asking detailed questions, that is concerning.
Baseline Lab Work
Before any peptide is prescribed, a responsible clinician will order baseline laboratory testing. This serves two purposes: confirming you are an appropriate candidate, and establishing baseline values to measure your response against later.[2]
The specific labs ordered will depend on which peptides are being considered, but a comprehensive baseline typically includes a complete blood count (CBC), comprehensive metabolic panel (CMP), thyroid function tests, and a relevant hormone panel. For growth hormone secretagogues specifically, IGF-1 levels and fasting glucose are standard. For anyone over 40 or with cardiovascular risk factors, a lipid panel and cardiovascular markers are also appropriate.
Labs typically take 3–7 business days to return. Your clinician will review the results with you before finalising any protocol.
Protocol Design and Prescription
Once lab results are reviewed, your clinician will design a personalised protocol. This includes the specific peptide or peptides, the dose, the frequency of administration, the timing (some peptides are most effective at specific times of day or in relation to sleep), and the duration of the initial cycle.
The prescription is sent to a licensed compounding pharmacy, which will prepare your peptides to pharmaceutical-grade standards. Turnaround from prescription to delivery is typically 5–10 business days. You should receive your medication along with administration instructions and a Certificate of Analysis confirming purity and potency.
Your clinician or their team should walk you through the administration protocol before you begin — including how to reconstitute a lyophilised (freeze-dried) peptide if applicable, how to draw and administer a subcutaneous injection, storage requirements, and what to do if you miss a dose.[3]
Starting the Protocol
Most therapeutic peptide protocols begin with a lower introductory dose for the first 1–2 weeks before titrating up to the target dose. This "ramp-up" period allows your body to adjust and helps identify any immediate adverse reactions before you are at a full therapeutic dose.
Keeping a simple symptom diary during the first 4–6 weeks is strongly recommended. Note energy levels, sleep quality, injection site reactions, mood, and any unexpected changes. This information is genuinely useful at your follow-up appointment and helps your clinician make informed adjustments.
Monitoring and Follow-Up
Peptide therapy is not a set-and-forget treatment. A well-run program includes scheduled follow-up appointments — typically at 4–6 weeks, then at 3 months, then quarterly or as clinically indicated. Follow-up labs are used to assess your biological response to the protocol and check for any changes in markers that warrant dose adjustment.
Your clinician should be accessible between appointments if you have concerns or experience unexpected effects. A protocol that has no monitoring structure is not being managed responsibly.[4]
Protocol Review and Adjustment
Based on your lab results and reported experience, your clinician will review and potentially adjust your protocol. This might mean changing the dose, modifying the timing, cycling off a peptide temporarily, or adding a complementary compound. Most protocols are reviewed and refined over a 3–6 month window before a longer-term approach is established.
It is also entirely appropriate — and in fact healthy — for you and your clinician to periodically reassess whether continuing therapy is warranted. Goals evolve, circumstances change, and a good clinician will always be asking whether the benefit-risk calculation still makes sense for you.
What Lab Tests to Expect
The specific labs ordered before starting peptide therapy vary by clinician and by the peptides being considered. The table below gives a general overview of common baseline markers and why each is relevant:
| Lab Test | What It Measures | Why It Matters for Peptide Therapy |
|---|---|---|
| Complete Blood Count (CBC) | Red cells, white cells, platelets | Establishes baseline immune and haematological health; identifies anaemia or immune disorders |
| Comprehensive Metabolic Panel (CMP) | Kidney, liver, glucose, electrolytes | Assesses organ function and metabolic baseline; flags conditions that affect peptide metabolism |
| IGF-1 (Insulin-like Growth Factor 1) | Downstream marker of growth hormone activity | Essential for GH secretagogue protocols; used to guide dosing and monitor response |
| Fasting Glucose / HbA1c | Blood sugar regulation | Relevant for GLP-1 agonists and GH peptides; important for monitoring metabolic effects |
| Thyroid Panel (TSH, T3, T4) | Thyroid hormone levels | Thyroid dysfunction can affect peptide response and energy levels |
| Testosterone / Oestrogen / DHEA | Sex hormone levels | Baseline for hormone-adjacent peptide protocols; detects existing imbalances |
| Lipid Panel | Cholesterol and triglycerides | Baseline cardiovascular risk assessment; some peptides affect lipid profiles |
| C-Reactive Protein (CRP) | Systemic inflammation marker | Relevant for repair and recovery peptides; monitors anti-inflammatory effects |
How Peptides Are Administered
The most common administration route for therapeutic peptides is subcutaneous injection — a small needle inserted just beneath the skin, typically into the abdomen or thigh. If this sounds daunting, it is worth noting that the needles used are very fine (typically 29–31 gauge, similar to insulin needles), and most patients find the process straightforward after the first few attempts. Injection site discomfort is generally minimal.[3]
Peptides are injected subcutaneously rather than intravenously because they need to be absorbed gradually through the surrounding tissue — the subcutaneous route mimics the body's natural peptide release pattern more closely than a direct intravenous bolus. Your clinician or pharmacy should provide detailed instructions and demonstrate the technique before you administer your first dose.
Other Administration Routes
Depending on the peptide and the goal, some protocols use alternative delivery methods:
- Nasal sprays — Used for some neuropeptides (e.g., Selank, Semax) and PT-141
- Oral capsules — Increasingly available but bioavailability is significantly lower for most peptides; only appropriate for peptides specifically formulated for oral delivery
- Topical creams — Used for some skin-targeted peptides; systemic absorption is generally low
Storage and Handling
Most compounded peptides arrive as lyophilised (freeze-dried) powder in sealed vials, which must be reconstituted with bacteriostatic water before use. Reconstituted peptides are typically stored in the refrigerator and used within a defined window (usually 28–60 days, depending on the compound). Unopened vials should be kept frozen until needed. Your pharmacy will provide specific storage instructions — follow them carefully, as improper storage can degrade the peptide.
Realistic Timeline: What to Expect and When
One of the most important expectations to set correctly is the timeline. Peptide therapy is not a quick fix. Changes occur gradually as the body's biological systems respond to sustained signalling — not overnight. The following timeline reflects general patterns for growth hormone secretagogue and repair peptide protocols:
Important Expectation
Individual variation is real and significant. Two people on the same peptide at the same dose can have noticeably different response timelines based on age, baseline hormone levels, metabolic health, sleep quality, nutrition, and genetics. A timeline that worked for someone else may not be your timeline — and that is normal, not a sign that the therapy is failing.
Common Side Effects: What's Normal and What Isn't
Common — Generally Manageable
- Injection site redness, minor swelling, or itching
- Mild fatigue in the first 1–2 weeks
- Vivid dreams (particularly with GH secretagogues)
- Transient water retention
- Mild headaches during the first week
- Nausea (most common with GLP-1 agonists, typically dose-dependent)
- Tingling or numbness in extremities (GH-related; usually transient)
Stop and Contact Your Clinician
- Severe or persistent injection site reactions
- Rapid or irregular heartbeat
- Significant blood pressure changes
- Unusual joint pain or swelling
- Persistent or severe nausea and vomiting
- Significant mood changes or emotional instability
- Any signs of allergic reaction (hives, difficulty breathing)
- Unexplained lumps or swelling anywhere in the body
The general principle: mild, transient side effects that resolve within the first 1–2 weeks are common and not a cause for concern. Anything persistent, severe, or that affects your cardiovascular system warrants prompt contact with your prescribing clinician — not a Google search.[4]
Who Peptide Therapy Is Not Appropriate For
Peptide therapy is not a universal option. There are genuine contraindications — medical circumstances in which specific peptides (and in some cases all peptides that stimulate growth pathways) should not be used.
- Active cancer or recent cancer history — Growth hormone secretagogues, BPC-157, and other pro-angiogenic peptides may theoretically stimulate dormant tumour growth. Most clinicians consider active cancer or recent cancer history a contraindication for peptides that activate growth pathways.
- Pregnancy and breastfeeding — Safety data for therapeutic peptides during pregnancy is insufficient. Most peptide protocols are contraindicated during pregnancy and breastfeeding.
- Uncontrolled diabetes — Some peptides (particularly GH secretagogues) can affect insulin sensitivity. Uncontrolled blood sugar should be addressed before starting these protocols.
- Hormone-sensitive conditions — Certain peptides that affect oestrogen, testosterone, or growth hormone levels may be contraindicated with conditions like hormone-receptor-positive cancers, polycystic ovary syndrome, or endometriosis — depending on the specific compound.
- Autoimmune conditions — Some immune-modulating peptides may interact with existing autoimmune conditions or medications used to treat them.
- Serious cardiovascular disease — CJC-1295 in particular has been associated with increased heart rate in some studies. Patients with significant cardiac history should discuss this carefully with their clinician.
Lifestyle Factors That Affect How Well Peptide Therapy Works
Peptide therapy is a medical intervention, not a lifestyle replacement. How well it works is significantly affected by the context into which it is introduced. Clinicians who run structured peptide programs consistently observe that patients who optimise the following lifestyle factors get better results — and that patients who neglect them often plateau or don't respond as expected.
Sleep
Many therapeutic peptides — particularly growth hormone secretagogues — work by amplifying the body's natural GH pulse, which occurs primarily during deep sleep. If you are chronically sleep-deprived or have disordered sleep, the efficacy of these peptides is meaningfully reduced. Addressing sleep hygiene is one of the most impactful things you can do alongside a GH peptide protocol.
Resistance Training
For protocols targeting body composition, lean muscle, and recovery, resistance training is not optional — it is part of the mechanism. Peptides that signal tissue repair and growth hormone production work synergistically with the signals generated by exercise-induced muscle stress. Sedentary patients using these protocols typically see significantly less benefit.
Protein Intake
Peptides can signal the body to build and repair — but they cannot build tissue out of nothing. Adequate dietary protein provides the raw material for the processes being signalled. Most clinicians prescribing body composition protocols recommend a protein intake of 1.6–2.2g per kilogram of body weight daily as a baseline.
Alcohol and Other Substances
Regular alcohol consumption blunts growth hormone secretion, impairs sleep architecture, and places additional load on the liver — all of which reduce the efficacy of peptide protocols. Your clinician should ask about alcohol use as part of the intake conversation, and some protocols will include specific guidance on this.
Summary: What Legitimate Peptide Therapy Looks Like
A properly run peptide therapy program is characterised by patience, personalisation, and professional oversight at every stage. It starts with a thorough consultation and baseline labs. It involves a prescription to a licensed pharmacy and pharmaceutical-grade compounds. It includes clear instructions for administration, realistic expectations for timeline, and scheduled follow-up monitoring.
It is also characterised by honesty about what it cannot do. Peptide therapy is a tool — one with genuine clinical utility in the right context, under the right conditions, for the right person. It is not a shortcut, not a substitute for fundamental health practices, and not appropriate for everyone.
The patients who get the most from peptide therapy tend to be those who approach it as part of a broader, medically guided health strategy — not as a standalone fix. That orientation, combined with qualified clinical support and pharmaceutical-grade products, is the foundation of everything that follows.
Ready to find out if peptide therapy is right for you?
Our free quiz takes 3 minutes and helps you understand your goals, your candidacy, and what a next step might look like — before you speak to a clinician.
Take Our Peptide Plan Quiz →References
- True You Health and Wellness. What to Expect During Your First Peptide Therapy Appointment. November 2025. Available from: https://trueyouhealthandwellness.com
- Delta Peptides. Peptide Safety Protocols: Clinical Guidelines. Available from: https://deltapeptides.com/safety
- Innerbody Research. Beginner's Guide to Peptide Therapy. January 2026. Available from: https://www.innerbody.com/beginners-guide-to-peptide-therapy
- Greenwich Medical Spa. Peptide Therapy Explained: What It Is, Which Peptides Work & How to Stay Safe. February 2026. Available from: https://www.greenwichmedicalspa.com
- Forbes J, Krishnamurthy K. Biochemistry, Peptide. StatPearls [Internet]. NIH/NCBI. 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562260/
- KS Wellness MD. Peptide Therapy Guide: Everything to Know Before Starting. 2025. Available from: https://kswellnessmd.com/peptide-therapy/